This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
Progenics Pharmaceuticals Inc
PGNX : NASDAQ : Health Care
$6.36 | %
Today's Range: 0.00 - 0.00
Avg. Daily Volume: 1,116,800
01/26/15 - 4:00 PM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
PGNX PROGENICS PHARMACEUTICAL INC 6.18 429.86 123.60 47.92 247.74
SRPT SAREPTA THERAPEUTICS INC 12.22 504.81 n/m 12.36 -34.73
DVAX DYNAVAX TECHNOLOGIES CORP 17.99 473.07 n/m 11.60 13.63
VNDA VANDA PHARMACEUTICALS INC 11.91 463.31 n/m 43.57 31.96
IMMU IMMUNOMEDICS INC 4.81 447.97 n/m 4.62 -50.95
SPPI SPECTRUM PHARMACEUTICALS INC 6.79 446.51 n/m 176.49 -0.20
XOMA XOMA CORP 3.50 404.15 n/m 27.05 -10.75
CTIC CTI BIOPHARMA CORP 2.23 400.93 n/m 75.17 4090.18
IDRA IDERA PHARMACEUTICALS INC 4.60 394.73 n/m 0.08 38.88
RTRX RETROPHIN INC 13.61 363.39 n/m 14.12 n/a
ARWR ARROWHEAD RESEARCH CORP 6.63 362.88 n/m 0.18 -39.66
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

PGNX Ind Avg S&P 500
123.60 83.11 19.47
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades


Top Rated Stocks Top Rated Funds Top Rated ETFs